Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis. This evidence concerns the gene GLP1R and metabolic dysfunction-associated steatotic liver disease.